Drug Information
Drug (ID: DG00586) and It's Reported Resistant Information
| Name |
Corticosteroids
|
||||
|---|---|---|---|---|---|
| Drug Resistance Disease(s) |
Disease(s) with Clinically Reported Resistance for This Drug
(2 diseases)
[1]
[2]
|
||||
| Target | . | NOUNIPROTAC | [2] | ||
| Click to Show/Hide the Molecular Information and External Link(s) of This Drug | |||||
| TTD Drug ID | |||||
Type(s) of Resistant Mechanism of This Drug
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-04: Immune system diseases
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Key Molecule: Multidrug resistance protein 1 (ABCB1) | [2] | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Resistant Disease | Lupus erythematosus [ICD-11: 4A40.0] | |||
| Experimental Note | Identified from the Human Clinical Data | |||
| Experiment for Molecule Alteration |
Flow cytometry assay | |||
| Mechanism Description | Several studies on patients with systemic autoimmune diseases in particular SLE, RA and PsA have demonstrated a significant correlation between P-gp expression/function, disease activity and the development of resistance to immunosuppressive therapy. | |||
| Key Molecule: Multidrug resistance protein 1 (ABCB1) | [2] | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Resistant Disease | Lupus erythematosus [ICD-11: 4A40.0] | |||
| Experimental Note | Identified from the Human Clinical Data | |||
| Experiment for Molecule Alteration |
Flow cytometry assay | |||
| Mechanism Description | Several studies on patients with systemic autoimmune diseases in particular SLE, RA and PsA have demonstrated a significant correlation between P-gp expression/function, disease activity and the development of resistance to immunosuppressive therapy. | |||
References
visits since 2022
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.
